psilocybin Archives

Psychedelics News

psilocybin

Law & Politics

23 Sep 2025

Psylutions and the DEA

In August 2025, the psychedelics movement crossed an unprecedented threshold. The U.S. Drug Enforcement Administration (DEA) announced that it would forward a petition to reschedule psilocybin, the psychoactive compound found...

By Madison Roberts

Law & Politics

9 Dec 2023

US Congress Adds Psychedelics Studies to Defense Bill

A bipartisan group of congressional lawmakers from both the House and the Senate have added funding for studies of psychedelic therapies into a major defense bill....

By Jason Najum

Science

27 Nov 2023

New Study Looks at Shame, Guilt and the Psychedelic Experience

A new study looks at emotionally painful, shame-related processes with psychedelic use....

By Microdose NewsDesk

Law & Politics

29 Sep 2023

Canadian Military Veteran Receives Approval for Psilocybin Therapy

Health Canada has granted permission for a Canadian military veteran to receive much-needed psilocybin therapy....

By Jason Najum

Join Our Newsletter for Exclusive Updates, Stories, and More

Don’t Miss

5 Sep 2023

News You Might Have Missed: Sep 5th, 2023

Welcome to the News You Might Have Missed, a weekly roundup of psychedelic medicine news to help you catch up and stay informed....

By Microdose NewsDesk

Science

1 Sep 2023

Usona Publishes Results of Phase 2 Psilocybin Trial for Depression

Results of the Usona Institute’s Phase 2 trial using psilocybin for depression were published yesterday....

By Microdose NewsDesk

Science

31 Aug 2023

New Johns Hopkins Study Shows Psilocybin Helps Long Term Mental Health

A new study from Johns Hopkins shows that psilocybin use promotes positive long-term effects on well-being....

By Jason Najum

Industry

15 Aug 2023

Cybin Granted U.S. Patent For Psilocybin Program

Newly granted U.S. patent covers composition of matter claims and treatment methods in support of the Company’s CYB003 program until 2041...

By Microdose NewsDesk

Breaking News, Science

17 Jul 2023

Positive Data From COMPASS Pathways’ Phase 2 Trial Combining Psilocybin & SSRIs

Results of COMPASS Pathways’ study suggests that SSRIs do not interfere with the potential therapeutic effect of COMP360...

By Microdose NewsDesk

Follow us on social

Latest News

Trump’s Psychedelic Fast-Track Order Changes the Timeline. It Also Redraws the Competitive Map.

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result